Home›Companies›Healthcare›Bullseye Biodevices

Bullseye Biodevices, Inc.

Develops tissue-sensing devices to help physicians assess patients during surgery.

Updated Nov 9, 2026·Latest SEC filing Aug 10, 2026·Suggest an edit

About Bullseye Biodevices

Bullseye Biodevices is a private company based in Hoboken, New Jersey, incorporated in 2024 in Delaware. It has reported $1,299,999 raised in one offering on Form D since August 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 28, 2026Aug 10, 2026$1,299,999fully sold1$1.2MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bullseye Biodevices's Form D filed Aug 10, 2026.

JK
Jinho Kim
CTO, Co-Founder and director
MM
Mohammad Mir
Project Leader and director

Sources

  1. SECBullseye Biodevices, Inc. filing history
  2. CompanyBullseye Biodevices investment announcement
  3. ResearchNSF awardee details